Metabolic effects of fenfluramine in obese diabetics
- PMID: 334212
- PMCID: PMC1429146
- DOI: 10.1111/j.1365-2125.1977.tb00781.x
Metabolic effects of fenfluramine in obese diabetics
Abstract
1 In a single-blind, cross-over study fenfluramine in a daily dose of 120 mg was found to reduce the daily blood glucose level moderately in hospitalized obese diabetics treated with a 1200 calorie diabetic diet. 2 After 7 days of treatment, fenfluramine was found not to influence the intravenous glucose tolerance, the insulin response to intravenously administered glucose, or the growth hormone response to arginine. 3 No changes in blood levels of lactate, beta hydroxybutyrate, triglycerides or cholesterol were seen during fenfluramine treatment.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
